|
|
|

INFLUENZA VACCINE
|
-
The US FDA approved
FluMist, by MedImmune, for use in people 2-49 years
of age. This expansion now includes children
2-5 years of age.
FDA Press Release (9-19-07)
-
The US FDA approved Glaxo
SmithKline's FluLaval influenza virus vaccine.
FluLaval is for adults 18 years and older to protect
against strains of influenza projected to impact the
Northern Hemisphere in the 2006/07 flu season.
FluLaval is manufactured by ID Biomedical Corp (a
Canadian subsidiary of GlaxoSmithKline) and
distributed by GSK.
FDA Press Release (10-05-06)
-
The US FDA announces
approval of Fluarix, an inactivated influenza
vaccine for adults. Fluarix is manufactured in
Germany by a subsidiary of GlaxoSmithKline.
FDA Press Release (08-31-05)
-
CDC's guidelines for
controlling influenza transmission in long-term care
facilities (06-06-05).
PDF (150k) |
HTML version
-
A new Influenza
vaccine will be available for the 2005/6 Flu Season:
The FDA has approved the license supplement of
sanofi
pasteur (formerly Aventis Pasteur) to market a
formula of their influenza vaccine produced without
introducing preservatives at any step in the
manufacturing process. Fluzone®, Influenza Virus
Vaccine, No Preservative, Pediatric Dose is the only
influenza vaccine approved for use in the U.S. in children as
young as 6 months. The vaccine will be available in
0.25 mL pediatric dose and 0.50 mL for children 3
years and older.
complete press release (03-09-05)
-
CDC's National
Immunization Program's
Influenza Vaccine
Bulletin with information on the latest
developments.
-
The Centers for
Disease Control and Prevention has added a web page
called "Influenza
(Flu) Protect Yourself & Your Loved Ones"
containing a wide variety of information and updates
on influenza including the map shown below.

|
|
This page
was last updated on
November 03, 2008
© 2008
Institute for Vaccine Safety
|
|